Curtis Lockshin Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curtis Lockshin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curtis Lockshin. Curtis Lockshin is a Director in Sorrento Therapeutics, Inc. ($SRNE) and a Chief Sciencific Officer in Xenetic Biosciences, Inc. ($XBIO) and a Chief Scientific Officer in Xenetic Biosciences, Inc. ($XBIO) and a Director in RXi Pharmaceuticals Corp ($RXII).
Address: 4400 BISCAYNE BOULEVARD SUITE 950 MIAMI 33137 FL
Companies in which Curtis Lockshin is an Insider
Phio Pharmaceuticals Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Curtis Lockshin: Director
Holdings: 10,366 shares
Current Value: $6,634
Latest Transaction: Mar 03 2021
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sorrento Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Curtis Lockshin: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 22 2009
$SRNE Market Capitalization: $312.87M
$SRNE Previous Close: $5.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xenetic Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Curtis Lockshin: Chief Sciencific Officer, Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 22 2021
$XBIO Market Capitalization: $38.54M
$XBIO Previous Close: $4.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Curtis Lockshin
Sentiment: All, PHIO, SRNE, XBIO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | XBIO | Xenetic Bioscience ... | Lockshin Curtis | Chief Sciencific Of ... | Option Exercise | A | 2.60 | 50,000 | 130,000 | 50,000 | |
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,366 | 366 to 10.4 K (+2,732.24 %) |
| Dec 06 2019 | XBIO | Xenetic Bioscience ... | Lockshin Curtis | Chief Scientific Of ... | Option Exercise | A | 1.31 | 90,000 | 117,900 | 90,000 | |
| Feb 15 2019 | RXII | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 20,130 | 10.1 K to 20.1 K (+98.72 %) |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,130 | 130 to 10.1 K (+7,692.31 %) |
| Feb 03 2017 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.63 | 2,000 | 1,258 | 2,000 | |
| Feb 12 2016 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.29 | 16,666 | 4,763 | 16,666 |